Zobrazeno 1 - 5
of 5
pro vyhledávání: '"José Laurent Cohen"'
Autor:
Eliane Piaggio, Allan Thiolat, Anais Debesset, Caroline Pilon, Benoît Laurent Salomon, José Laurent Cohen, Sylvain Baulande, Sylvain Meunier, Orianne Cuelenaere-Bonizec, Wilfrid Richer, Claire Houppe, Matteo Ponzo, Jeanne Magnan, Jonathan Caron, Pamela Caudana, Jimena Tosello Boari, Nhu Han To, Ilaria Cascone
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 11 (2024)
Background Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive cancers, highly resistant to standard chemotherapy and immunotherapy. Regulatory T cells (Tregs) expressing tumor necrosis factor α receptor 2 (TNFR2) contribute to imm
Externí odkaz:
https://doaj.org/article/3f68bef7704c46289269850f3be85bc5
Autor:
Frédéric Charlotte, Allan Thiolat, Audrey Moatti, Anais Debesset, Caroline Pilon, Asma Beldi-Ferchiou, Mathieu Leclerc, Rabah Redjoul, Nhu Hanh To, Adeline Bak, Yazid Belkacemi, Benoît Laurent Salomon, Fadi Issa, David Michonneau, Sebastien Maury, José Laurent Cohen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 4 (2022)
Externí odkaz:
https://doaj.org/article/ff96a6b49dd945428ea80df5322f4e3e
Autor:
Louis Pérol, John M. Lindner, Pamela Caudana, Nicolas Gonzalo Nunez, Audrey Baeyens, Andrea Valle, Christine Sedlik, Delphine Loirat, Olivier Boyer, Alain Créange, José Laurent Cohen, Ute Christine Rogner, Jun Yamanouchi, Martine Marchant, Xavier Charles Leber, Meike Scharenberg, Marie-Claude Gagnerault, Roberto Mallone, Manuela Battaglia, Pere Santamaria, Agnès Hartemann, Elisabetta Traggiai, Eliane Piaggio
Publikováno v:
Nature Communications, Vol 7, Iss 1, Pp 1-10 (2016)
Type 1 diabetes is driven by T-cell autoimmunity to pancreatic islet cells. Here the authors show that autoreactive anti-IL-2 T and B cells are present in type 1 diabetes patients, and that anti-IL-2 antibodies precede diabetes onset in mice, suggest
Externí odkaz:
https://doaj.org/article/db770a8739b84dbf870ffd96cace147e
Autor:
Audrey Moatti, Anais Debesset, Caroline Pilon, Asma Beldi-Ferchiou, Mathieu Leclerc, Rabah Redjoul, Frederic Charlotte, Nhu Hanh To, Adeline Bak, Yazid Belkacemi, Benoît Laurent Salomon, Fadi Issa, David Michonneau, Sebastien Maury, José Laurent Cohen, Allan Thiolat
BackgroundTargeting immune checkpoints that inhibit antitumor immune responses has emerged as a powerful new approach to treat cancer. We recently showed that blocking the tumor necrosis factor receptor-type 2 (TNFR2) pathway induces the complete los
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f99ee9feb4642449f2288eb1eb589f27
https://ora.ox.ac.uk/objects/uuid:c6e7f8a8-a970-49ac-aec6-eeabaf782903
https://ora.ox.ac.uk/objects/uuid:c6e7f8a8-a970-49ac-aec6-eeabaf782903
Autor:
Benoît, Vingert, Marie, Tamagne, Maxime, Desmarets, Sadaf, Pakdaman, Rahma, Elayeb, Anoosha, Habibi, Françoise, Bernaudin, Frédéric, Galacteros, Philippe, Bierling, France, Noizat-Pirenne, José Laurent, Cohen, José, Cohen
Publikováno v:
American Journal of Hematology
American Journal of Hematology, Wiley, 2013, 89, pp.261-266. ⟨10.1002/ajh.23629⟩
American Journal of Hematology, Wiley, 2013, 89, pp.261-266. ⟨10.1002/ajh.23629⟩
International audience; Sickle cell disease (SCD) is a chronic inflammatory disease associated with multiple organ damage, chronic anemia, and infections. SCD patients have a high rate of alloimmunization against red blood cells (RBCs) following tran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c391e3a5ae0602db37e2a5e8c03927fe
https://pubmed.ncbi.nlm.nih.gov/24779034
https://pubmed.ncbi.nlm.nih.gov/24779034